West Oak Capital’s Bioverativ Inc. Common Stock BIVV Stock Holding History

West Oak Capital’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-43	Closed	-$2.32K	–	379
2017 Q4	$2.32K	Hold	43	–	–	﹤0.01%	278
2017 Q3	$2.45K	Sell	43 -249	-85%	-$14.6K	﹤0.01%	311
2017 Q2	$17.6K	Sell	292 -1,319	-82%	-$75.1K	0.01%	249
2017 Q1	$87.7K	Buy	+1,611	New	+$79.4K	0.05%	152

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

West Oak Capital's BIVV Position: Q1 2018 in Review

West Oak Capital sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 43 shares — an estimated $2.32K sold.

West Oak Capital first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $87.7K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

West Oak Capital reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
West Oak Capital sold 43 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.32K.
West Oak Capital first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
West Oak Capital's Bioverativ Inc. Common Stock position peaked at $87.7K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on West Oak Capital's 13F filing for Q1 2018, filed 5 Apr 2018.